In this study, we found that the structures of GZMA-cysteine complex and GZMH-cysteine complex were in equilibrium after simulation and in a stable state throughout the MD simulation, indicating that the peripheral blood metabolite cysteine binds most strongly to the core protein GZMA/GZMH in AD patients. The gene discussed is GZMH; the disease is Alzheimer disease.